Lloyd’s 2022 medical start-up syndicate seeks ILS, Names capital

The former QBE underwriting team behind the 1.1.22 Lloyd’s medical start-up syndicate are expected to attract backing from both ILS funds and third-party Names’ capital, The Insurer can reveal.


Want to read this article?


For details on how to subscribe or for all commercial opportunities, including advertising, please contact:

Spencer Halladey

Commercial director

+44 (0) 7540 000929


    Andy Stone

    Sales manager

    +44 (0) 7834 843176